US2017312102A1PendingUtilityA1
Biodegradable supporting device
Est. expiryMar 9, 2032(~5.6 yrs left)· nominal 20-yr term from priority
Inventors:Eric K. Mangiardi
A61F 2/844A61L 31/088A61K 31/337A61F 2002/91575A61L 2420/04A61B 2017/00588A61L 31/005A61L 2300/416A61F 2310/00065A61L 2400/12A61F 2310/00041A61F 2/07A61F 2210/0009A61F 2250/003A61L 31/16A61L 31/022A61L 2420/08A61F 2/82A61L 31/10A61K 31/436A61F 2210/0004A61F 2210/0076A61L 2300/64A61L 31/148A61F 2/86B82Y 5/00A61F 2/915A61B 17/12113A61B 2017/00592A61B 17/12109A61B 2017/00632A61F 2/90A61L 31/14A61P 9/04A61F 2002/91583A61F 2250/0067A61B 17/0057A61P 35/00A61L 2420/02A61F 2230/0069
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A biodegradable in vivo supporting device is disclosed. In one embodiment, a coated stent device includes a biodegradable metal alloy scaffold made from a magnesium alloy, iron alloy, zinc alloy, or combination thereof, and the metal scaffold comprises a plurality of metal struts. The metal struts are at least partially covered with a biodegradable polymer coating. A method for making and a method for using a biodegradable in vivo supporting device are also disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A biodegradable in vivo supporting device, comprising:
a biodegradable metal alloy scaffold comprising a plurality of metal struts; and a biodegradable polymer coating at least partially covering the metal struts.
2 . The device of claim 1 , wherein the metal struts have an average cross-sectional thickness between 100-200 μm, the polymer coating has a thickness between 10-100 μm.
3 . The device of claim 1 , wherein the biodegradable metal alloy scaffold comprises a magnesium alloy, an iron alloy, a zinc alloy, or combination thereof.
4 . The device of claim 3 , wherein the alloy further comprises one or more metals selected from the group consisting of manganese, magnesium, neodymium, cerium, iron, zinc, palladium, cobalt, aluminum, tungsten, boron, carbon, sulfur, silicon, lithium, zirconium, calcium, and yttrium.
5 . The device of claim 1 , wherein the metal alloy further comprises at least one rare earth metal and a majority of the metal alloy comprises magnesium.
6 . The device of claim 5 , wherein the rare earth metal is neodymium or cerium.
7 . The device of claim 1 , wherein the biodegradable metal scaffold is made from a magnesium alloy having at least 96 wt. % of magnesium, at least 1 wt. % of manganese, and at least 0.5 wt. % of a rare earth metal.
8 . The device of claim 7 , wherein the biodegradable metal scaffold is made from a magnesium alloy having a magnesium content of 96-97.9 wt. %, a manganese content of 1.6-2 wt. %, and rare earth metal content of 0.5-2 wt. %.
9 . The device of claim 7 , wherein the biodegradable metal scaffold is made from a magnesium alloy having a magnesium content of 97.45 wt. %, a manganese content of 1.8 wt. %, and a neodymium content of 0.75 wt. %.
10 . The device of claim 1 , wherein the biodegradable metal scaffold is an expandable scaffold.
11 . The device of claim 1 , wherein the metal scaffold is less than 60% w/w or less than 60% v/v of the device.
12 . The device of claim 1 , wherein the biodegradable polymer coating is permeable to body fluid.
13 . The device of claim 1 , wherein the biodegradable polymer comprises PLLA, PLGA, or a combination thereof.
14 . The device of claim 1 , wherein the biodegradable polymer coating has one or more holes allowing direct contact between the metal struts and body fluids when the stent device is placed inside a body lumen.
15 . The device of claim 1 , wherein the biodegradable polymer coating comprises an anti-proliferative agent selected from the group consisting of paclitaxel, sirolimus, docetaxel, biolimus A9, zotarolimus, everolimus, myolimus, novolimus, pimecrolimus, tacrolimus, ridaforolimus, temsirolimus and combination thereof.
16 . The device of claim 1 , further comprising an additional coating between the metal alloy scaffold and the biodegradable coating that delays the degradation time of the metal alloy scaffold.
17 . The device of claim 16 , wherein the additional coating is a nano-coating of iron.
18 . A biodegradable in vivo supporting device, comprising:
a biodegradable metal alloy scaffold made from a magnesium alloy, an iron alloy, a zinc alloy, or combination thereof, the metal scaffold comprising a plurality of metal struts; a biodegradable polymer coating at least partially covering the metal struts, wherein the metal struts have an average cross-sectional thickness between 100-200 μm, the polymer coating has a thickness between 10-100 μm.
19 . A biodegradable in vivo supporting device, comprising:
a biodegradable metal alloy scaffold made from a magnesium alloy having a magnesium content of 97.45 wt. %, a manganese content of 1.8 wt. %, and a neodymium or cerium content of 0.75 wt. %, the metal scaffold comprising a plurality of metal struts; a biodegradable polymer coating at least partially covering the metal struts, wherein the metal struts have an average cross-sectional thickness between 100-200 μm, the polymer coating has a thickness between 10-100 μm.
20 . A method for treating a condition in a subject with a biodegradable in vivo supporting device, comprising:
establishing an entry portal into a body lumen in a subject in need of such treatment; and delivering said supporting device to a target location through said body lumen; and deploying said supporting device at the target location, wherein said biodegradable in vivo supporting device comprises a biodegradable metal alloy scaffold comprising a plurality of metal struts and a biodegradable polymer coating at least partially covering the metal struts.
21 . The method of claim 20 , wherein said body lumen is a blood vessel.
22 . The method of claim 21 , wherein said blood vessel is a cardiac blood vessel.
23 . The method of claim 22 , wherein the metal struts have an average cross-sectional thickness between 100-200 μm, the polymer coating has a thickness between 10-100 μm.
24 . A kit for placement of a biodegradable in vivo supporting device, comprising:
a biodegradable in vivo supporting device comprising a biodegradable metal alloy scaffold comprising a plurality of metal struts and a biodegradable polymer coating at least partially covering the metal struts, and a guide wire.Join the waitlist — get patent alerts
Track US2017312102A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.